Literature DB >> 7730679

Transesophageal echocardiographic determinants of embolism in nonrheumatic atrial fibrillation.

R Mitusch1, V Lange, U Stierle, B Maurer, A Sheikhzadeh.   

Abstract

The purpose of the study was to determine the relation of transesophageal echocardiographic findings to symptoms of systemic embolism in patients with nonrheumatic atrial fibrillation. Transthoracic and transesophageal echocardiography were used to study 107 patients with atrial fibrillation including 49 patients without embolic complications and 58 patients who had suffered from previous cerebral or peripheral embolism. A multiple logistic regression analysis revealed that left atrial thrombi (odds ratio 9.0, 95% CI 2.4-33.6, p < 0.005) and the presence of dense left atrial spontaneous contrast (odds ratio 8.4, 95% CI 1.3-53.1, p < 0.05) were independently related to embolic symptoms. Intensive left atrial spontaneous contrast was associated with an increased left atrial diameter (odds ratio 2.0, 95% CI 1.1-3.6, p < 0.05), the presence of chronic atrial fibrillation (odds ratio 6.9, 95% CI 1.6-29.8, p < 0.01) and aortic atherosclerosis (odds ratio 2.6, 95% CI 1.2-5.5, p < 0.05). It was further negatively correlated to mitral regurgitation (odds ratio 0.4, 95% CI 0.2-0.9, p < 0.05). In conclusion, dense spontaneous echo contrast and left atrial thrombi are associated to thromboembolic complications in patients with nonrheumatic atrial fibrillation. Classifying of spontaneous contrast seems to be useful when estimating the thromboembolic risk in atrial fibrillation.

Entities:  

Mesh:

Year:  1995        PMID: 7730679     DOI: 10.1007/bf01148951

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  35 in total

1.  Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

2.  Patent foramen ovale or left atrial thrombi in unexplained arterial embolism.

Authors:  A Mügge; W G Daniel; P Wenzlaff; P R Lichtlen
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

3.  Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors:  P Petersen; J Kastrup; S Helweg-Larsen; G Boysen; J Godtfredsen
Journal:  Arch Intern Med       Date:  1990-04

4.  Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Authors:  P A Wolf; T R Dawber; H E Thomas; W B Kannel
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

5.  Left atrial spontaneous contrast echoes--markers of thromboembolic risk in patients with atrial fibrillation.

Authors:  M A de Belder; L B Lovat; L Tourikis; G Leech; A Camm
Journal:  Eur Heart J       Date:  1993-03       Impact factor: 29.983

6.  Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces.

Authors:  A Merino; P Hauptman; L Badimon; J J Badimon; M Cohen; V Fuster; M Goldman
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

7.  Transesophageal Doppler echocardiography of pulmonary venous flow: a new marker of mitral regurgitation severity.

Authors:  A L Klein; T P Obarski; W J Stewart; P N Casale; G L Pearce; K Husbands; D M Cosgrove; E E Salcedo
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

8.  Stroke Prevention in Atrial Fibrillation Study. Final results.

Authors: 
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

9.  Atrial septal aneurysm and stroke: a transesophageal echocardiographic study.

Authors:  A C Pearson; D Nagelhout; R Castello; C R Gomez; A J Labovitz
Journal:  J Am Coll Cardiol       Date:  1991-11-01       Impact factor: 24.094

10.  Ultrasonography of blood during stasis and coagulation.

Authors:  B Sigel; J C Coelho; D G Spigos; D P Flanigan; J J Schuler; D O Kasprisin; L M Nyhus; V Capek
Journal:  Invest Radiol       Date:  1981 Jan-Feb       Impact factor: 6.016

View more
  3 in total

1.  Rapid achievement of therapeutic anticoagulation positively affects outcome in patients undergoing cardioversion for persistent atrial fibrillation.

Authors:  Ray Cutro; Thomas A Burkart; Anne B Curtis
Journal:  Clin Cardiol       Date:  2006-02       Impact factor: 2.882

Review 2.  Percutaneous Left Atrial Appendage Exclusion Therapy: Who, Why and How?

Authors:  Sven Möbius-Winkler; Ingo Dähnert; Gerhard C Schuler; Peter B Sick
Journal:  J Atr Fibrillation       Date:  2009-10-01

Review 3.  Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States.

Authors:  Kamakshi Lakshminarayan; David C Anderson; Charles A Herzog; Adnan I Qureshi
Journal:  Neurologist       Date:  2008-05       Impact factor: 1.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.